Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562-Reference-Cited by-同舟云学术

Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562

Published:1999-07 Issue:1 Volume:106 Page:78-85
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:British Journal of Haematology

Author:

Dumontet Charles,Fabianowska-Majewska Krystyna,Mantincic Danko,Callet Bauchu Evelyne,Tigaud Isabelle,Gandhi Varsha,Lepoivre Michel,Peters Godefridus J.,Rolland Marie Odile,Wyczechowska Dorota,Fang Xiao,Gazzo Sophie,Voorn Daphne A.,Vanier-Viornery Armelle,Mackey John

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.1999.01509.x/fullpdf

Reference40 articles.

1. Nucleoside transport in normal and neoplastic cells;Belt;Advances in Enzyme Regulation,1993

2. Molecular identification of the equilibrative NBMPR-sensitive (es) nucleoside transporter and demonstration of an equilibrative NBMPR-insensitive (ei) transport activity in human erythroleukemia (K562) cells;Boletti;Neuropharmacology,1997

3. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;Journal of Clinical Oncology,1997

4. dic(4;17) (p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disorders;Callet-Bauchu;Genes, Chromosomes and Cancer,1996

5. New antimetabolites in the treatment of human malignancies;Cheson;Seminars in Oncology,1992

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into the Basic Mechanisms and Various Modulation Strategies Involved in Cancer Drug Resistance;Current Cancer Drug Targets;2023-11

2. The Prognostic Significance of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase on the outcome of Adult Acute Myeloid Leukemia Patients with Cytarabine Based Chemotherapy;International Journal of Hematology and Oncology;2022-04-30

3. Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers;Cancers;2021-02-25

4. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma;Investigational New Drugs;2020-12-09

5. The novel L-nucleoside analogue, 5-Fluorotroxacitabine, displays potent efficacy against acute myeloid leukemia;Haematologica;2019-12-19